ArticleCureus2025
7p21.1 Microdeletion Encompassing the ACTB Gene in a Japanese Child: Longitudinal Clinical and Neuroimaging Findings.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a Japanese male with genetically confirmed 7p21.1 microdeletion encompassing ACTB, followed longitudinally from infancy to late childhood. The patient presented at 10 months of age with microcephaly, short stature, global developmental delay, bilateral esotropia, and atypical Y-shaped deep plantar creases. Early evaluations excluded congenital infections and chromosomal abnormalities. At age four years and eight months, a brain MRI revealed multiple cystic lesions in the deep white matter near the left lateral ventricular trigone and scattered punctate hyperintensities, which remained unchanged at age 11 years and 10 months. Developmental assessments demonstrated persistent cognitive impairment (developmental quotient (DQ): 73 at age two years; 65 at age seven years). He also had growth restriction (height -2.7 SD at final follow-up), without seizures or major systemic malformations. This case represents one of the few Japanese reports of 7p21.1 microdeletion encompassing ACTB with a detailed clinical course over more than a decade and highlights an uncommon neuroradiological finding, deep white matter cysts, which may broaden the recognized phenotype. Our findings underscore the diagnostic value of exome sequencing in children with syndromic developmental delay when conventional evaluations are inconclusive and the importance of careful physical examination in early infancy to detect subtle anomalies that may provide critical diagnostic clues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.